Drivers of healthcare costs associated with the episode of care for surgical aortic valve replacement versus transcatheter aortic valve implantation.

Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation - rationale and design of the FAST-TAVI registry. BMC Cardiovasc Disord (2017) 0.75

Short Length of Stay After Elective Transfemoral Transcatheter Aortic Valve Replacement is Not Associated With Increased Early or Late Readmission Risk. J Am Heart Assoc (2017) 0.75

Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med (2010) 22.04

Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med (2011) 15.70

Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med (2016) 6.95

A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J (2003) 6.88

Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med (2012) 6.27

Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med (2014) 5.88

Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med (2012) 4.47

2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2014) 3.59

Review of statistical methods for analysing healthcare resources and costs. Health Econ (2010) 2.27

Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol (2014) 1.80

2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement. J Am Coll Cardiol (2015) 1.75

Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes (2013) 1.68

Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: results from the Placement of Aortic Transcatheter Valve trial. Circ Cardiovasc Interv (2014) 1.49

Cost effectiveness of transcatheter aortic valve replacement compared to medical management in inoperable patients with severe aortic stenosis: Canadian analysis based on the PARTNER Trial Cohort B findings. J Med Econ (2013) 1.48

A comparison of several regression models for analysing cost of CABG surgery. Stat Med (2003) 1.31

Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications. Eur Heart J (2012) 1.29

Valvular heart disease: the next cardiac epidemic. Heart (2010) 1.22

Cost-effectiveness of transcatheter aortic valve implantation versus surgery for high-risk patients with aortic stenosis. J Am Coll Cardiol (2013) 1.09

Cost effectiveness of drug eluting coronary artery stenting in a UK setting: cost-utility study. Heart (2005) 1.06

Estimating the number of coronary artery bypass graft and percutaneous coronary intervention procedures in Canada: a comparison of cardiac registry and Canadian Institute for Health Information data sources. Can J Cardiol (2010) 0.93

The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk. Heart (2013) 0.92

Cost of transcatheter aortic valve implantation and factors associated with higher hospital stay cost in patients of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Arch Cardiovasc Dis (2013) 0.91

Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation. Health Technol Assess (2013) 0.89

Cost effectiveness of transcatheter aortic valve replacement compared with medical management or surgery for patients with aortic stenosis. Appl Health Econ Health Policy (2015) 0.88

Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective. J Thorac Cardiovasc Surg (2012) 0.84

Risk stratification and clinical pathways to optimize length of stay after transcatheter aortic valve replacement. Can J Cardiol (2014) 0.81

Cost-effectiveness considerations in transcatheter management of valvular heart disease. Can J Cardiol (2014) 0.80

Analysis of the additional costs of clinical complications in patients undergoing transcatheter aortic valve replacement in the German Health Care System. Int J Cardiol (2014) 0.79

Transfemoral aortic valve implantation: bleeding events, related costs and outcomes. J Thromb Thrombolysis (2013) 0.79

Identifying predictors of cumulative healthcare costs in incident atrial fibrillation: a population-based study. J Am Heart Assoc (2015) 0.79

Cost-effectiveness of TAVR in the non-surgical population. J Med Econ (2013) 0.77

Abstracts: Pulse: a report on the UHC Annual Conference 2013, October 17-18, Atlanta, GA. Am J Med Qual (2014) 0.77

Hospitalization costs ofTAVI in one Belgian university hospital. Acta Cardiol (2013) 0.77

Could a "Simplified" Transcatheter Aortic Valve Replacement Procedure Eliminate Post-Operative Delirium? JACC Cardiovasc Interv (2016) 0.76